Related references
Note: Only part of the references are listed.Fusobacterium nucleatum stimulates cell proliferation and promotes PD-L1 expression via IFIT1-related signal in colorectal cancer
Yaqi Gao et al.
NEOPLASIA (2023)
Molecular and Pathology Features of Colorectal Tumors and Patient Outcomes Are Associated with Fusobacterium nucleatum and Its Subspecies animalis
Ivan Borozan et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2022)
Tumour burden and efficacy of immune-checkpoint inhibitors
Filippo G. Dall'Olio et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2022)
Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer
Jorge Luis Galeano Nino et al.
NATURE (2022)
Cancer as microenvironmental, systemic and environmental diseases: opportunity for transdisciplinary microbiomics science
Kentaro Inamura et al.
GUT (2022)
Fusobacterium is enriched in oral cancer and promotes induction of programmed death-ligand 1 (PD-L1)
Chieko Michikawa et al.
NEOPLASIA (2022)
A meta-analysis of CD274 (PD-L1) assessment and prognosis in colorectal cancer and its role in predicting response to anti-PD-1 therapy
Peter G. Alexander et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2021)
Fusobacterium nucleatum Promotes the Progression of Colorectal Cancer Through Cdk5-Activated Wnt/β-Catenin Signaling
Xiang Li et al.
FRONTIERS IN MICROBIOLOGY (2021)
Association of Fusobacterium nucleatum with Specific T-cell Subsets in the Colorectal Carcinoma Microenvironment
Jennifer Borowsky et al.
CLINICAL CANCER RESEARCH (2021)
Relationship between microsatellite status and immune microenvironment of colorectal cancer and its application to diagnosis and treatment
Junge Bai et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2021)
Molecular subtypes of colorectal cancer: An emerging therapeutic opportunity for personalized medicine
Manish Pratap Singh et al.
GENES & DISEASES (2021)
Association of autophagy status with amount of Fusobacterium nucleatum in colorectal cancer
Koichiro Haruki et al.
JOURNAL OF PATHOLOGY (2020)
Combined prognostic value of CD274 (PD-L1)/PDCDI (PD-1) expression and immune cell infiltration in colorectal cancer as per mismatch repair status
Maarit Ahtiainen et al.
MODERN PATHOLOGY (2019)
Fusobacterium nucleatum Contributes to the Carcinogenesis of Colorectal Cancer by Inducing Inflammation and Suppressing Host Immunity
Jiao Wu et al.
TRANSLATIONAL ONCOLOGY (2019)
PTEN Alterations as a Potential Mechanism for Tumor Cell Escape from PD-1/PD-L1 Inhibition
Daniele Cretella et al.
CANCERS (2019)
Low-dose aspirin can reduce colorectal cancer mortality after surgery: A 10-year follow-up of 13 528 colorectal cancer patients
Joseph J. Y. Sung et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2019)
Utility of inverse probability weighting in molecular pathological epidemiology
Li Liu et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2018)
Diets That Promote Colon Inflammation Associate With Risk of Colorectal Carcinomas That Contain Fusobacterium nucleatum
Li Liu et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)
Genetic Mechanisms of Immune Evasion in Colorectal Cancer
Catherine S. Grasso et al.
CANCER DISCOVERY (2018)
The Amount of Bifidobacterium Genus in Colorectal Carcinoma Tissue in Relation to Tumor Characteristics and Clinical Outcome
Keisuke Kosumi et al.
AMERICAN JOURNAL OF PATHOLOGY (2018)
Insights into Pathogenic Interactions Among Environment, Host, and Tumor at the Crossroads of Molecular Pathology and Epidemiology
Shuji Ogino et al.
Annual Review of Pathology-Mechanisms of Disease (2018)
Clinical significance of programmed death 1 ligand-1 (CD274/PD-L1) and intra-tumoral CD8+T-cell infiltration in stage II-III colorectal cancer
Chih-Yang Huang et al.
SCIENTIFIC REPORTS (2018)
Fusobacterium nucleatum in Colorectal Cancer Relates to Immune Response Differentially by Tumor Microsatellite Instability Status
Tsuyoshi Hamada et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Tumour CD274 (PD-L1) expression and T cells in colorectal cancer
Yohei Masugi et al.
GUT (2017)
Clinicopathologic profile, immunophenotype, and genotype of CD274 (PD-L1)-positive colorectal carcinomas
Shingo Inaguma et al.
MODERN PATHOLOGY (2017)
Aspirin Use and Colorectal Cancer Survival According to Tumor CD274 (Programmed Cell Death 1 Ligand 1) Expression Status
Tsuyoshi Hamada et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer
Susan Bullman et al.
SCIENCE (2017)
Histopathological and genotypic characterization of metastatic colorectal carcinoma with PD-L1 (CD274)-expression: Possible roles of tumour micro environmental factors for CD274 expression
Shingo Inaguma et al.
JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2017)
Association of Dietary Patterns With Risk of Colorectal Cancer Subtypes Classified by Fusobacterium nucleatum in Tumor Tissue
Raaj S. Mehta et al.
JAMA ONCOLOGY (2017)
The mortality reducing effect of aspirin in colorectal cancer patients: Interpreting the evidence
Martine A. Frouws et al.
CANCER TREATMENT REVIEWS (2017)
Control of PD-L1 Expression by Oncogenic Activation of the AKT-mTOR Pathway in Non-Small Cell Lung Cancer
Kristin J. Lastwika et al.
CANCER RESEARCH (2016)
Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis
Kosuke Mima et al.
GUT (2016)
Fusobacterium nucleatum in Colorectal Carcinoma Tissue According to Tumor Location
Kosuke Mima et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2016)
Binding of the Fap2 Protein of Fusobacterium nucleatum to Human Inhibitory Receptor TIGIT Protects Tumors from Immune Cell Attack
Chamutal Gur et al.
IMMUNITY (2015)
Fusobacterium nucleatum and T Cells in Colorectal Carcinoma
Kosuke Mima et al.
JAMA ONCOLOGY (2015)
Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome
L. Flanagan et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2014)
Analyses of clinicopathological, molecular, and prognostic associations of KRAS codon 61 and codon 146 mutations in colorectal cancer: cohort study and literature review
Yu Imamura et al.
MOLECULAR CANCER (2014)
PD-L1 Expression in Triple-Negative Breast Cancer
Elizabeth A. Mittendorf et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
Aleksandar D. Kostic et al.
CELL HOST & MICROBE (2013)
Fusobacterium nucleatum Promotes Colorectal Carcinogenesis by Modulating E-Cadherin/β-Catenin Signaling via its FadA Adhesin
Mara Roxana Rubinstein et al.
CELL HOST & MICROBE (2013)
The Activation of MAPK in Melanoma Cells Resistant to BRAF Inhibition Promotes PD-L1 Expression That Is Reversible by MEK and PI3K Inhibition
Xiaofeng Jiang et al.
CLINICAL CANCER RESEARCH (2013)
Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy
Reiko Nishihara et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Genomic analysis identifies association of Fusobacterium with colorectal carcinoma
Aleksandar D. Kostic et al.
GENOME RESEARCH (2012)
Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum
Mai Yamauchi et al.
GUT (2012)
Aspirin Use, Tumor PIK3CA Mutation, and Colorectal-Cancer Survival
Xiaoyun Liao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Precision of Pyrosequencing Assay to Measure LINE-1 Methylation in Colon Cancer, Normal Colonic Mucosa, and Peripheral Blood Cells
Natsumi Irahara et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2010)
Lymphocytic Reaction to Colorectal Cancer Is Associated with Longer Survival, Independent of Lymph Node Count, Microsatellite Instability, and CpG Island Methylator Phenotype
Shuji Ogino et al.
CLINICAL CANCER RESEARCH (2009)
Comprehensive Biostatistical Analysis of CpG Island Methylator Phenotype in Colorectal Cancer Using a Large Population-Based Sample
Katsuhiko Nosho et al.
PLOS ONE (2008)
Share Paper
